My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    Recent advances in systemic therapy: advances in adjuvant systemic chemotherapy of early breast cancer.

    López-Tarruella S, Martín M.

    Breast Cancer Res. 2009;11(2):204. Epub 2009 Mar 19. Review.

    PMID:
    19344489
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.

    PMID:
    17993229
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.

    Goble S, Bear HD.

    Surg Clin North Am. 2003 Aug;83(4):943-71. Review.

    PMID:
    12875604
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

    [No authors listed]

    CMAJ. 1998 Feb 10;158 Suppl 3:S52-64. Review.

    PMID:
    9484279
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    [Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes].

    Nagykálnai T.

    Magy Onkol. 2002;46(4):307-13. Epub 2003 Feb 1. Review. Hungarian.

    PMID:
    12563352
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    6.

    Adjuvant therapy for breast cancer.

    Hennessy BT, Pusztai L.

    Minerva Ginecol. 2005 Jun;57(3):305-26. Review.

    PMID:
    16166938
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Adjuvant therapy of primary breast cancer: a review of key findings from the 7th international conference, St. Gallen, February 2001.

    Aapro MS.

    Oncologist. 2001;6(4):376-85. Review.

    PMID:
    11524557
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    8.

    Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.

    Dobbe E, Gurney K, Kiekow S, Lafferty JS, Kolesar JM.

    Am J Health Syst Pharm. 2008 Jan 1;65(1):23-8. Review.

    PMID:
    18159035
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Medical management of early-stage breast cancer.

    Bookman MA, Goldstein LJ, Scher RM.

    Curr Probl Cancer. 1991 Jul-Aug;15(4):157-232. Review.

    PMID:
    1874006
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group.

    Martin M, Villar A, Sole-Calvo A, Gonzalez R, Massuti B, Lizon J, Camps C, Carrato A, Casado A, Candel MT, Albanell J, Aranda J, Munarriz B, Campbell J, Diaz-Rubio E; GEICAM Group (Spanish Breast Cancer Research Group), Spain.

    Ann Oncol. 2003 Jun;14(6):833-42. Review.

    PMID:
    12796019
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    11.

    Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.

    Shapiro CL, Gelman RS, Hayes DF, Osteen R, Obando A, Canellos GP, Frei E 3rd, Henderson IC.

    J Natl Cancer Inst. 1993 May 19;85(10):812-7.

    PMID:
    8487326
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    [Current trends in pharmacotherapy of breast cancer].

    Boér K.

    Orv Hetil. 2002 Apr 7;143(14):725-30. Review. Hungarian.

    PMID:
    11975393
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Adjuvant systemic therapy for women with node-negative breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

    [No authors listed]

    CMAJ. 1998 Feb 10;158 Suppl 3:S43-51. Review.

    PMID:
    9484278
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results.

    Zambetti M, Valagussa P, Bonadonna G.

    Ann Oncol. 1996 Jul;7(5):481-5.

    PMID:
    8839902
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    15.

    Current and future status of adjuvant therapy for breast cancer.

    Coleman RE.

    Cancer. 2003 Feb 1;97(3 Suppl):880-6. Review.

    PMID:
    12548590
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    16.

    Genomic predictors of outcome and treatment response in breast cancer.

    Dunn L, Demichele A.

    Mol Diagn Ther. 2009;13(2):73-90. doi: 10.2165/01250444-200913020-00002. Review.

    PMID:
    19537843
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Adjuvant therapy for breast cancer.

    [No authors listed]

    NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.

    PMID:
    11512506
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    The curability of breast cancer and the treatment of advanced disease.

    Guarneri V, Conte PF.

    Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S149-61. Epub 2004 Apr 24. Review.

    PMID:
    15107948
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Selection criteria for epirubicin-based adjuvant chemotherapy in node-negative breast cancer.

    Jänicke F.

    Clin Breast Cancer. 2000 Sep;1 Suppl 1:S57-61. Review.

    PMID:
    11970751
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    20.

    A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: the paradoxical role of Bcl-2 oncoprotein (review).

    Kim R, Osaki A, Toge T.

    Int J Oncol. 2001 Nov;19(5):1075-80. Review.

    PMID:
    11605012
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk